当前位置:  首页 >> 最新重要论文

最新重要论文

Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopically Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy, Adv Funct Mater, 16 Apr 2021

发布时间:2021年04月16日

Advanced Functional Materials, 16 April, 2021, DOI:盛大彩票幸运28

Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopically Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy

Zhuoran Wang, Shuai Zhang, Ruofei Zhang, Xuehui Chen, Guoming Sun, Meng Zhou, Qiubai Han, Baoli Zhang, Yue Zhao, Bing Jiang, Yili Yang, Xiyun Yan, Kelong Fan

Abstract

A biocompatible and modifiable protein nanocarrier is a promising candidate for tumor targeted drug delivery. However, it is challenging to effectively load hydrophobic drugs, not to mention to upload both hydrophilic and hydrophobic drugs on one protein nanocarrier. Here, an amphiphilic multi‐drug loading protein nanocage (Am‐PNCage) is presented which is generated by replacing the fifth helix of human H‐ferritin (HFn) subunit with a functional motif composed of hydrophobic–hydrophilic‐RGD peptides. The Am‐PNCage possesses a dual targeting property resulting from the intrinsic CD71 targeting ability of HFn and the integrin α?vβ3 targeting ability of displayed RGD peptides. Through the hydrophilic drug entry channel in the protein nanocage and hydrophobic peptides displayed on the outer surface, amphiphilic epirubicin (132)/camptothecin (50) are stereoscopically loaded into the inner cavity/outer protein shell, respectively, for one Am‐PNCage, exhibiting cascade drug release pattern. The dual‐targeted Am‐PNCage promotes the loaded drugs penetrating various 3D tumor models in vitro, as well as traversing the brain blood barrier and accumulating in brain tumors in vivo. Moreover, the drug loaded Am‐PNCage shows reduced side effects and significantly enhances synergistic efficacy against brain tumor, metastatic liver cancers, and drug resistant breast tumor. Thus, the Am‐PNCage represents a novel promising protein nanocarrier for targeted combination chemotherapy.

文章链接:https://onlinelibrary.wiley.com/doi/10.1002/adfm.202102004

文章报道:http://sdcpxy28.766bbin.com/kyjz/zxdt/202104/t20210421_5995190.html

 

 

    附件下载:
网站地图 盛大彩票江苏快三 百合彩票斯洛伐克5分彩 盛大彩票新疆时时彩
十大博彩现金网申博 澳门太阳城官方网站 申博官方网 申博信誉第一
金沙彩票平台可靠吗直营网 sunbet申博官网登录登入 大富彩票网手机登入 百合彩票北京快3
盛大彩票澳洲3分彩 盛大彩票新疆时时彩 百合彩票新加坡2分彩 盛大彩票六合彩
盛大彩票澳洲28 盛大彩票重庆时时彩 百合彩票幸运农场 盛大彩票台湾5分彩
368PT.COM 153sun.com 581tt.com 618XTD.COM 318XTD.COM
788cw.com 98csb.com uk138.com 538sj.com 537SUN.COM
756SUN.COM 678jbs.com 8TFS.COM 44sbsun.com 688XTD.COM
67jbs.com 658XTD.COM 176sun.com 538PT.COM 304sun.com